ArticleBMC neurology2014

Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.

MerriKay Oleen-Burkey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.